DSIP 10mg

What is DSIP?

DSIP was identified in 1977 from the venous blood of rabbits induced into slow-wave sleep, giving the peptide its name even though its physiological role has since proven broader than sleep alone. It is a short, well-defined nonapeptide rather than a peptide mixture.

This listing is DSIP 10mg from Imperial Peptides (Australia), sold on Stairway to Gray with escrow: your payment is held until the order arrives and only then released to the brand.

How it is understood to work

DSIP is thought to modulate delta-wave sleep architecture and to interact with the hypothalamic-pituitary-adrenal axis, including corticotropin and luteinizing hormone release, and has shown antioxidant and stress-buffering activity in laboratory models. The precise receptor or binding target for DSIP has not been conclusively established, so much of its mechanism remains descriptive rather than fully mapped.

Research status

Research on DSIP spans sleep regulation, circadian biology, stress physiology, and pain-modulation models, largely in animal and in vitro systems dating back several decades. It has not progressed to an approved clinical product, and more recent literature on the peptide is comparatively sparse next to newer research compounds.

Specifications

Compound

DSIP

Also known as

Delta Sleep-Inducing Peptide

Class

Neuropeptide (nonapeptide)

Form

Lyophilized (freeze-dried) powder

Per vial

10mg

Brand

Imperial Peptides · Australia

Handling & storage

Supplied as a lyophilized powder; store unopened vials frozen and protected from light, and keep any reconstituted solution refrigerated, using it within the timeframe set by your study protocol.

Concentration check: adding 2 ml of bacteriostatic water to one 10mg vial gives 5 mg/ml. The Research Lab calculator in your dashboard works this out for any volume.

Questions

For laboratory research use only. Not for human or veterinary use. Nothing on this page is medical advice.